Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Regulation of CDK4.

Laurence Bockstaele1, Katia Coulonval, Hugues Kooken

  • 1Institute of Interdisciplinary Research (IRIBHM), Faculté de Médecine, Université Libre de Bruxelles, Campus Erasme, B-1070 Brussels, Belgium. Laurence.Bockstaele@ulb.ac.be

Cell Division
|November 10, 2006
PubMed
Summary

Cyclin-dependent kinase 4 (CDK4) activation is key to cell cycle control and cancer. New findings highlight T-loop phosphorylation as a critical, yet debated, regulatory step for CDK4, impacting its role in cell cycle progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CDK4/6 inhibition uncovers subtype-specific vulnerabilities and immune-related responses in esophageal squamous cell carcinoma.

Cell death & disease·2026
Same author

Dysregulation of Inositol Polyphosphate 5-Phosphatase OCRL in Alzheimer's Disease: Implications for Autophagy Dysfunction.

International journal of molecular sciences·2025
Same author

CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas.

Frontiers in endocrinology·2023
Same author

RHOJ controls EMT-associated resistance to chemotherapy.

Nature·2023
Same author

CDK4/6 Inhibitors in Pancreatobiliary Cancers: Opportunities and Challenges.

Cancers·2023
Same author

An Activity-Based Oxaziridine Platform for Identifying and Developing Covalent Ligands for Functional Allosteric Methionine Sites: Redox-Dependent Inhibition of Cyclin-Dependent Kinase 4.

Journal of the American Chemical Society·2022

Area of Science:

  • Molecular biology
  • Cell cycle regulation
  • Cancer research

Background:

  • Cyclin-dependent kinase 4 (CDK4) integrates extracellular signals to regulate the cell cycle.
  • CDK4 plays a significant role in oncogenic transformation processes.
  • Key aspects of CDK4 activation, including cyclin D association, subcellular localization, and Thr172-phosphorylation, are not fully understood.

Purpose of the Study:

  • To review and clarify poorly understood molecular features of CDK4 activation.
  • To discuss the role of Cip/Kip CDK inhibitors in CDK4 regulation.
  • To present recent findings on T-loop phosphorylation as a critical regulatory mechanism for CDK4.

Main Methods:

  • Literature review of CDK4 activation mechanisms.
  • Analysis of molecular features regulating CDK4 function.

Related Experiment Videos

  • Recent experimental identification of T-loop phosphorylation in CDK4.

    • Main Results:

    • CDK4 activation involves complex regulation of its association with D-type cyclins and subcellular localization.
    • The activating Thr172-phosphorylation of CDK4 is a critical target for cell cycle control.
    • T-loop phosphorylation of CDK4, unlike CDK6, is identified as a determining factor for cell cycle control by extracellular signals.

    Conclusions:

    • The regulation of CDK4 activation is multifaceted, involving cyclin binding, localization, and phosphorylation.
    • Recent findings suggest that the kinases responsible for CDK4 activation may require re-evaluation.
    • Understanding these regulatory mechanisms is crucial for targeting CDK4 in cancer therapy.